Trial Profile
Phase II trial of farnesoid X receptor agonists in patients with chronic hepatitis B
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 May 2015
Price :
$35
*
At a glance
- Drugs Farnesoid X-activated receptor agonists (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 11 May 2015 New trial record